CN114558064A - 一种中药组合物、制备方法及应用 - Google Patents
一种中药组合物、制备方法及应用 Download PDFInfo
- Publication number
- CN114558064A CN114558064A CN202210272152.1A CN202210272152A CN114558064A CN 114558064 A CN114558064 A CN 114558064A CN 202210272152 A CN202210272152 A CN 202210272152A CN 114558064 A CN114558064 A CN 114558064A
- Authority
- CN
- China
- Prior art keywords
- parts
- traditional chinese
- chinese medicine
- medicine composition
- raw materials
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 71
- 239000003814 drug Substances 0.000 title claims abstract description 68
- 238000002360 preparation method Methods 0.000 title claims abstract description 24
- 239000002994 raw material Substances 0.000 claims abstract description 30
- 235000009411 Rheum rhabarbarum Nutrition 0.000 claims abstract description 21
- 240000001659 Oldenlandia diffusa Species 0.000 claims abstract description 19
- 244000110343 Elephantopus scaber Species 0.000 claims abstract description 18
- 244000219416 Hypericum japonicum Species 0.000 claims abstract description 18
- 241001139545 Mallotus apelta Species 0.000 claims abstract description 17
- 244000247747 Coptis groenlandica Species 0.000 claims abstract description 16
- 235000002991 Coptis groenlandica Nutrition 0.000 claims abstract description 16
- 240000003824 Gypsophila paniculata Species 0.000 claims abstract description 15
- 244000135727 Abrus pulchellus subsp cantoniensis Species 0.000 claims abstract description 13
- 235000017112 Abrus pulchellus subsp cantoniensis Nutrition 0.000 claims abstract description 13
- 241000132171 Phryma leptostachya Species 0.000 claims abstract description 10
- 238000004090 dissolution Methods 0.000 claims abstract description 6
- 244000299790 Rheum rhabarbarum Species 0.000 claims abstract 3
- 238000002791 soaking Methods 0.000 claims description 38
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 22
- 239000000843 powder Substances 0.000 claims description 22
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 20
- 238000009835 boiling Methods 0.000 claims description 18
- 238000000227 grinding Methods 0.000 claims description 15
- 238000000034 method Methods 0.000 claims description 11
- 238000001035 drying Methods 0.000 claims description 9
- 239000000706 filtrate Substances 0.000 claims description 9
- 238000001914 filtration Methods 0.000 claims description 9
- 238000005303 weighing Methods 0.000 claims description 9
- 239000002245 particle Substances 0.000 claims description 7
- 239000008187 granular material Substances 0.000 claims description 4
- 241000205585 Aquilegia canadensis Species 0.000 claims description 3
- 240000005528 Arctium lappa Species 0.000 claims description 3
- 235000003130 Arctium lappa Nutrition 0.000 claims description 3
- 244000303040 Glycyrrhiza glabra Species 0.000 claims description 3
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims description 3
- 239000002775 capsule Substances 0.000 claims description 3
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims description 3
- 239000007788 liquid Substances 0.000 claims description 3
- 235000011477 liquorice Nutrition 0.000 claims description 3
- 239000006187 pill Substances 0.000 claims description 3
- 235000008078 Arctium minus Nutrition 0.000 claims description 2
- 230000008569 process Effects 0.000 claims description 2
- 239000003826 tablet Substances 0.000 claims description 2
- 238000009210 therapy by ultrasound Methods 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 33
- 210000004185 liver Anatomy 0.000 abstract description 26
- 208000006454 hepatitis Diseases 0.000 abstract description 25
- 231100000283 hepatitis Toxicity 0.000 abstract description 20
- 210000004369 blood Anatomy 0.000 abstract description 19
- 239000008280 blood Substances 0.000 abstract description 19
- 239000000463 material Substances 0.000 abstract description 19
- 231100000331 toxic Toxicity 0.000 abstract description 19
- 230000002588 toxic effect Effects 0.000 abstract description 19
- 229940079593 drug Drugs 0.000 abstract description 4
- 210000000232 gallbladder Anatomy 0.000 abstract description 4
- 239000002904 solvent Substances 0.000 abstract description 4
- 229940126680 traditional chinese medicines Drugs 0.000 abstract description 4
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 abstract description 3
- 239000011259 mixed solution Substances 0.000 abstract description 3
- 230000004044 response Effects 0.000 abstract description 2
- 239000000243 solution Substances 0.000 description 26
- 206010023126 Jaundice Diseases 0.000 description 20
- 208000002193 Pain Diseases 0.000 description 18
- 241000219061 Rheum Species 0.000 description 18
- 230000001737 promoting effect Effects 0.000 description 11
- 208000024891 symptom Diseases 0.000 description 11
- 208000004880 Polyuria Diseases 0.000 description 9
- 230000035619 diuresis Effects 0.000 description 9
- 210000002700 urine Anatomy 0.000 description 9
- 206010061428 decreased appetite Diseases 0.000 description 7
- 201000010099 disease Diseases 0.000 description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
- 230000008961 swelling Effects 0.000 description 7
- 244000018716 Impatiens biflora Species 0.000 description 6
- 235000015912 Impatiens biflora Nutrition 0.000 description 6
- 206010037660 Pyrexia Diseases 0.000 description 6
- 206010042674 Swelling Diseases 0.000 description 6
- 235000005155 Tanacetum balsamita Nutrition 0.000 description 6
- 238000002156 mixing Methods 0.000 description 6
- 239000012856 weighed raw material Substances 0.000 description 6
- 102100036475 Alanine aminotransferase 1 Human genes 0.000 description 5
- 108010082126 Alanine transaminase Proteins 0.000 description 5
- 206010008909 Chronic Hepatitis Diseases 0.000 description 5
- 230000036760 body temperature Effects 0.000 description 5
- 208000001848 dysentery Diseases 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 230000003908 liver function Effects 0.000 description 5
- 210000000952 spleen Anatomy 0.000 description 5
- 210000002784 stomach Anatomy 0.000 description 5
- 241000220436 Abrus Species 0.000 description 4
- BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 description 4
- 206010007247 Carbuncle Diseases 0.000 description 4
- 206010017553 Furuncle Diseases 0.000 description 4
- 206010028813 Nausea Diseases 0.000 description 4
- 206010030113 Oedema Diseases 0.000 description 4
- 230000036528 appetite Effects 0.000 description 4
- 235000019789 appetite Nutrition 0.000 description 4
- 210000004072 lung Anatomy 0.000 description 4
- 230000008693 nausea Effects 0.000 description 4
- 231100000419 toxicity Toxicity 0.000 description 4
- 230000001988 toxicity Effects 0.000 description 4
- 108010003415 Aspartate Aminotransferases Proteins 0.000 description 3
- 102000004625 Aspartate Aminotransferases Human genes 0.000 description 3
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 3
- 208000004078 Snake Bites Diseases 0.000 description 3
- 244000269722 Thea sinensis Species 0.000 description 3
- 238000008050 Total Bilirubin Reagent Methods 0.000 description 3
- 208000022531 anorexia Diseases 0.000 description 3
- 235000019658 bitter taste Nutrition 0.000 description 3
- 230000003203 everyday effect Effects 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- 230000000968 intestinal effect Effects 0.000 description 3
- 210000002429 large intestine Anatomy 0.000 description 3
- 230000002175 menstrual effect Effects 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 238000010926 purge Methods 0.000 description 3
- 210000003786 sclera Anatomy 0.000 description 3
- 230000004936 stimulating effect Effects 0.000 description 3
- 235000019640 taste Nutrition 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 230000008736 traumatic injury Effects 0.000 description 3
- 208000004998 Abdominal Pain Diseases 0.000 description 2
- 206010063659 Aversion Diseases 0.000 description 2
- 206010010741 Conjunctivitis Diseases 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- 241000037740 Coptis chinensis Species 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 208000004232 Enteritis Diseases 0.000 description 2
- 208000032843 Hemorrhage Diseases 0.000 description 2
- 206010019705 Hepatic pain Diseases 0.000 description 2
- 241000827125 Lupinus flavoculatus Species 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 201000005702 Pertussis Diseases 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- 206010000269 abscess Diseases 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 206010016256 fatigue Diseases 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 208000002672 hepatitis B Diseases 0.000 description 2
- 230000007794 irritation Effects 0.000 description 2
- 201000009240 nasopharyngitis Diseases 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 230000017423 tissue regeneration Effects 0.000 description 2
- 206010044008 tonsillitis Diseases 0.000 description 2
- 231100000611 venom Toxicity 0.000 description 2
- 230000008673 vomiting Effects 0.000 description 2
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 208000007743 Acute Abdomen Diseases 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 206010006895 Cachexia Diseases 0.000 description 1
- 241000887125 Chaptalia nutans Species 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 206010010726 Conjunctival oedema Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 241000195950 Equisetum arvense Species 0.000 description 1
- 239000005768 Equisetum arvense L. Substances 0.000 description 1
- 241000195955 Equisetum hyemale Species 0.000 description 1
- 201000000297 Erysipelas Diseases 0.000 description 1
- 108020004206 Gamma-glutamyltransferase Proteins 0.000 description 1
- 206010018286 Gingival pain Diseases 0.000 description 1
- 206010018291 Gingival swelling Diseases 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 206010019842 Hepatomegaly Diseases 0.000 description 1
- 208000007514 Herpes zoster Diseases 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 206010020741 Hyperpyrexia Diseases 0.000 description 1
- 208000006083 Hypokinesia Diseases 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 208000006877 Insect Bites and Stings Diseases 0.000 description 1
- 229930184510 Mallotus Natural products 0.000 description 1
- 241001060384 Mallotus <angiosperm> Species 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 240000000233 Melia azedarach Species 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 208000036626 Mental retardation Diseases 0.000 description 1
- 244000265736 Nelumbo pentapetala Species 0.000 description 1
- 235000006510 Nelumbo pentapetala Nutrition 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 206010067171 Regurgitation Diseases 0.000 description 1
- 240000004980 Rheum officinale Species 0.000 description 1
- 235000008081 Rheum officinale Nutrition 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 241000123725 Sophora tonkinensis Species 0.000 description 1
- 240000007641 Spergula rubra Species 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- 206010049514 Traumatic fracture Diseases 0.000 description 1
- 206010049590 Upper respiratory tract inflammation Diseases 0.000 description 1
- 206010048245 Yellow skin Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 206010000059 abdominal discomfort Diseases 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 235000019606 astringent taste Nutrition 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 201000005668 blepharoconjunctivitis Diseases 0.000 description 1
- 210000005252 bulbus oculi Anatomy 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- QTCANKDTWWSCMR-UHFFFAOYSA-N costic aldehyde Natural products C1CCC(=C)C2CC(C(=C)C=O)CCC21C QTCANKDTWWSCMR-UHFFFAOYSA-N 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 208000026500 emaciation Diseases 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 210000001508 eye Anatomy 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 102000006640 gamma-Glutamyltransferase Human genes 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 206010019847 hepatosplenomegaly Diseases 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- ISTFUJWTQAMRGA-UHFFFAOYSA-N iso-beta-costal Natural products C1C(C(=C)C=O)CCC2(C)CCCC(C)=C21 ISTFUJWTQAMRGA-UHFFFAOYSA-N 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 201000003453 lung abscess Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 201000008383 nephritis Diseases 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 238000009527 percussion Methods 0.000 description 1
- 210000003516 pericardium Anatomy 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 201000004647 tinea pedis Diseases 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 210000004916 vomit Anatomy 0.000 description 1
- 229940126673 western medicines Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/10—Bryophyta (mosses)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/19—Acanthaceae (Acanthus family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/34—Campanulaceae (Bellflower family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/38—Clusiaceae, Hypericaceae or Guttiferae (Hypericum or Mangosteen family), e.g. common St. Johnswort
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/708—Rheum (rhubarb)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/718—Coptis (goldthread)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
- A61K36/748—Oldenlandia or Hedyotis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
本申请提出了一种中药组合物、制备方法及应用,涉及医药技术领域。该中药组合物包括按重量份数计的以下原料:白背叶根5‑50份,黄莲5‑10份,鸡骨草5‑20份,田基黄5‑15份,满天星5‑30份,地胆草5‑10份,驳骨草5‑30份,蛇舌草5‑20份以及大黄5‑15份。该组合物原料全部为纯天然药材,且简单易得,九味中药相互作用,相互协同,具有清热解毒、化瘀散结、解毒利胆、抗毒护肝之功效。该组合物的制备方法以水‑乙醇混合溶液作为溶剂在煎煮的条件下将有效成分提取出来,可有效提升有效成分的溶出率,制备效果较好。该中药组合物在制备治疗黄疸型肝炎的药物中的应用,不仅治疗效果好,而且见效较快。
Description
技术领域
本申请涉及医药技术领域,具体而言,涉及一种中药组合物、制备方法及应用。
背景技术
黄疸型肝炎是由各种肝炎病毒或其它化学成分损伤肝脏造成的肝功能损坏,发病时其主要症状为身黄、目黄、尿黄、胁痛、皮肤瘙痒、面色晦暗、恶心、呕吐、厌油、肝大,严重的黄疸型肝炎患者有时会出现肝脏萎缩现象,通过化验科检查出肝功能异常,黄疸指数增高。重型黄疸型肝炎的死亡率较高,严重危害着人民群众的健康和生命安全。
目前,治疗黄疸型肝炎类的西药,主要通过抑制病毒来保肝降酶,从当前看,这些药物大多不理想,中医用药又参差不齐,鱼目混珠,难以奏效,耽误病情,久而久之成为慢性肝炎,久犯久治,久治不愈,甚至转化为肝硬化以至癌变。
发明内容
本申请的目的在于提供一种中药组合物,配方简单,对于治疗黄疸型肝炎有显著效果。
本申请的另一目的在于提供一种中药组合物的制备方法,该制备方法简单易行,适合批量生产,便于患者使用和携带。
本申请的另一目的在于提供一种中药组合物在制备治疗黄疸型肝炎的药物中的应用,所将该组合物制备成药物,不仅治疗效果好,而且见效较快。
本申请解决其技术问题是采用以下技术方案来实现的。
第一方面,本申请实施例提供一种中药组合物,包括按重量份数计的以下原料:白背叶根5-50份,黄莲5-10份,鸡骨草5-20份,田基黄5-15份,满天星5-30份,地胆草5-10份,驳骨草5-30份,蛇舌草5-20份以及大黄5-15份。
在本申请的一些实施例中,按重量份数计包括以下原料:白背叶根30份,黄莲6份,鸡骨草15份,田基黄8份,满天星20份,地胆草7份,驳骨草23份,蛇舌草13份以及大黄9份。
第二方面,本申请实施例提供一种中药组合物的制备方法,包括以下步骤:
按量称取原料,加入浸泡液浸泡0.5~1小时,加6~8倍量水煎煮,以武火煎煮至沸腾,再文火煎煮,保持微沸1~1.5小时,纱布滤过,药渣继续加5~6倍量浸泡液煎煮2次,每次各煎0.5~1小时,合并三次滤液,浓缩,干燥,研磨成粉末。
第三方面,本申请实施例提供一种一种中药组合物在制备治疗黄疸型肝炎的药物中的应用。
相对于现有技术,本申请的实施例至少具有如下优点或有益效果:
1.本申请实施例提供一种中药组合物,包括按重量份数计的以下原料:白背叶根5-50份,黄莲5-10份,鸡骨草5-20份,田基黄5-15份,满天星5-30份,地胆草5-10份,驳骨草5-30份,蛇舌草5-20份以及大黄5-15份。该组合物以白背叶根、鸡骨草和满天星治疗黄疸型肝炎,疏肝止痛,以黄莲、田基黄和驳骨草清热解毒,治疗并发症感冒发烧,以大黄、蛇舌草和地胆草利湿去黄,逐瘀通经。从而使其具有清热解毒、逐瘀通经、利湿退黄、疏肝止痛之功效,从而达到预期的治疗效果。原料全部为纯天然药材,且简单易得,无刺激,无毒副作用,制法简单易操作。经临床实践证明此九味中药相互作用,相互协同,具有清热解毒、化瘀散结、解毒利胆、抗毒护肝,祛瘀生新之功效。
2.本申请实施例提供一种中药组合物的制备方法,该制备方法以水-乙醇混合溶液作为溶剂在煎煮的条件下将有效成分提取出来,不仅简单易行,而且可有效提升有效成分的溶出率,制备效果较好。再制成药物,更加方便服用和携带,患者不需要每天煎煮,更加节省时间。
3.本申请实施例提供一种中药组合物在制备治疗黄疸型肝炎的药物中的应用,所将该组合物制备成药物,用于治疗黄疸型肝炎不仅治疗效果好,而且见效较快。
具体实施方式
为使本申请实施例的目的、技术方案和优点更加清楚,下面将对本申请实施例中的技术方案进行清楚、完整地描述。实施例中未注明具体条件者,按照常规条件或制造商建议的条件进行。所用试剂或仪器未注明生产厂商者,均为可以通过市售购买获得的常规产品。
需要说明的是,在不冲突的情况下,本申请中的实施例及实施例中的特征可以相互组合。下面将参考具体实施例来详细说明本申请。
第一,本申请提出一种中药组合物,包括按重量份数计的以下原料:白背叶根5-50份,黄莲5-10份,鸡骨草5-20份,田基黄5-15份,满天星5-30份,地胆草5-10份,驳骨草5-30份,蛇舌草5-20份以及大黄5-15份。各原料的具体功效如下:
如白背叶根:味微苦、涩,性平,归肝、脾经,根:柔肝活血,健脾化湿,收敛固脱。主治用于慢性肝炎,肝脾肿大,子宫脱垂,脱肛,白带淋浊,妊娠水肿。
黄莲:别名:味连、川连、鸡爪连,味苦,性寒。归心、脾、胃、肝、胆、大肠经。功效:清热燥湿,泻火解毒。主治湿热痞满,呕吐吞酸,泻痢,黄疸,高热神昏,心火亢盛,心烦不寐。
鸡骨草:甘、微苦,凉,归肝、胃经。有利湿退黄,清热解毒,疏肝止痛之功效。常用于湿热黄疽,胁肋不舒,胃脘胀痛,乳痈肿痛。
田基黄:味甘、苦,凉,归肺,肝,胃经。有清热利湿,解毒,散瘀消肿之功效。用于湿热黄疸,泄泻,痢疾,肠痈,痈疖肿毒,乳蛾,口疮,目赤肿痛,毒蛇咬伤,跌打损伤。
满天星:性平,味苦。有清热利尿,化痰止咳之功效。主治急性黄疸型肝炎、急性肾炎、百日咳、尿路结石、脚癣、带状皰疹、结膜炎、丹毒。具有祛风清热作用。
地胆草:味苦、辛,性寒,归肺、肝、肾经。具有清热,凉血,解毒,利湿之功效。常用于感冒,扁桃体炎,咽喉炎,百日咳,睑结膜炎,黄疸,肾炎水肿,月经不调,白带,湿疹,疮疖,虫蛇咬伤。
驳骨草:别名又叫:木贼、节节草、豆根草等。性凉味苦,归经肺,肝,脾,大肠经。具有清热解毒,祛风止痛的功能。主治感冒,肠炎,痢疾,风湿骨痛,跌打伤折。
蛇舌草:具有清热解毒,活血化淤,利湿退黄的功效。主治肺热咳嗽,肺痈,咽喉肿痛,肠痈,疖肿疮疡,毒蛇咬伤,热淋涩痛,水肿,痢疾肠炎,湿热黄疸,癌肿。
大黄:苦,寒。归脾、胃、大肠、肝、心包经。泻下攻积,清热泻火,凉血解毒,逐瘀通经,利湿退黄。用于实热积滞便秘,血热吐衄,目赤咽肿,痈肿疔疮,肠痈腹痛,瘀血经闭,产后瘀阻,跌打损伤,湿热痢疾,黄疸尿赤,淋证,水肿;外治烧烫伤。酒大黄善清上焦血分热毒。用于目赤咽肿,齿龈肿痛。熟大黄泻下力缓,泻火解毒。用于火毒疮疡。大黄炭凉血化瘀止血。用于血热有瘀出血症。
综上,该组合物以白背叶根、鸡骨草和满天星治疗黄疸型肝炎,疏肝止痛,以黄莲、田基黄和驳骨草清热解毒,治疗并发症感冒发烧,以大黄、蛇舌草和地胆草利湿去黄,逐瘀通经。从而使其具有清热解毒、逐瘀通经、利湿退黄、疏肝止痛之功效。
本申请的一些实施例中,一种中药组合物,按重量份数计包括以下原料:白背叶根30份,黄莲6份,鸡骨草15份,田基黄8份,满天星20份,地胆草7份,驳骨草23份,蛇舌草13份以及大黄9份。上述原料的配比用量为优选用量,此时,药物用量适中,在不降低治疗效果的同时,能够提升组合物的适用性。
第二,本申请实施例提供一种中药组合物的制备方法,包括以下步骤:
按量称取原料,加入浸泡液浸泡0.5~1小时,加6~8倍量水煎煮,以武火煎煮至沸腾,再文火煎煮,保持微沸1~1.5小时,纱布滤过,药渣继续加5~6倍量浸泡液煎煮2次,每次各煎0.5~1小时,合并三次滤液,浓缩,干燥,研磨成粉末。
具体的,浸泡液由水和乙醇制成,作为溶剂,乙醇分子可以快速浸润细胞壁,使得药物中的有效成分快速溶解与水中。相比于纯水,加入少量乙醇后,清润速度和溶解速度都更快。
本申请中,浸泡液中水和乙醇的体积比为(300-350):(10-30)。
为了提升中药原料的破壁效果,在浸泡过程中进行超声溶解,且超声的频率为35kHz-45kHz。
为了方便溶解以及更好的被人体吸收,将中药组合物研磨成粒径为100-150目的粉末。
本申请中,将中药组合物粉末制成丸剂、胶囊剂、片剂、散剂、颗粒剂或口服液,,更加方便服用和携带,患者不需要每天煎煮,更加节省时间。
第三,本申请实施例提供一种中药组合物在制备治疗黄疸型肝炎的药物中的应用,将该组合物制成药物,用于治疗黄疸型肝炎不仅治疗效果好,而且见效较快。
以下结合实施例对本申请的特征和性能作进一步的详细描述。
实施例1
本实施例的目的在于提供一种中药组合物,包括以下原料:白背叶根30g,黄莲6g,鸡骨草15g,田基黄8g,满天星20g,地胆草7g,驳骨草23g,蛇舌草13g以及大黄9g。
该组合物的制备方法具体如下:
按量称取原料,将300ml水与10ml乙醇混合得到浸泡液,然后将称取好的原料加入浸泡液中,超声浸泡0.5小时,超声的频率为35kHz,加6倍量水煎煮,以武火煎煮至沸腾,再文火煎煮,保持微沸1小时,纱布滤过,药渣继续加6倍量浸泡液煎煮2次,每次各煎0.5小时,合并三次滤液,浓缩,干燥,研磨成粉末。
将中药组合物研磨成粒径为100目的粉末,然后制成丸剂。
实施例2
本实施例的目的在于提供一种中药组合物,包括以下原料:白背叶根50g,黄莲10g,鸡骨草20g,田基黄15g,满天星30g,地胆草10g,驳骨草30g,蛇舌草20g以及大黄15g。
该组合物的制备方法具体如下:
按量称取原料,将350ml水与30ml乙醇混合得到浸泡液,然后将称取好的原料加入浸泡液中,超声浸泡1小时,超声的频率为45kHz,加8倍量水煎煮,以武火煎煮至沸腾,再文火煎煮,保持微沸1.5小时,纱布滤过,药渣继续加6倍量浸泡液煎煮2次,每次各煎1小时,合并三次滤液,浓缩,干燥,研磨成粉末。
将中药组合物研磨成粒径为110目的粉末,然后制胶囊剂。
实施例3
本实施例的目的在于提供一种中药组合物,包括以下原料:白背叶根25g,黄莲5g,鸡骨草10g,田基黄7.5g,满天星15g,地胆草5g,驳骨草15g,蛇舌草10g以及大黄7g,柴胡15g,甘草10g。
该组合物的制备方法具体如下:
按量称取原料,将320ml水与13ml乙醇混合得到浸泡液,然后将称取好的原料加入浸泡液中,超声浸泡0.6小时,超声的频率为40kHz,加6倍量水煎煮,以武火煎煮至沸腾,再文火煎煮,保持微沸1.2小时,纱布滤过,药渣继续加5倍量浸泡液煎煮2次,每次各煎0.8小时,合并三次滤液,浓缩,干燥,研磨成粉末。
将中药组合物研磨成粒径为120目的粉末,然后制成片剂。
实施例4
本实施例的目的在于提供一种中药组合物,包括以下原料:白背叶根40g,黄莲6g,鸡骨草15g,田基黄8g,满天星18g,地胆草7g,驳骨草15g,蛇舌草13g以及大黄9g,牛蒡子13g、金银花8g。
该组合物的制备方法具体如下:
按量称取原料,将330ml水与25ml乙醇混合得到浸泡液,然后将称取好的原料加入浸泡液中,超声浸泡0.5小时,超声的频率为35kHz,加6倍量水煎煮,以武火煎煮至沸腾,再文火煎煮,保持微沸1小时,纱布滤过,药渣继续加6倍量浸泡液煎煮2次,每次各煎0.5小时,合并三次滤液,浓缩,干燥,研磨成粉末。
将中药组合物研磨成粒径为130目的粉末,然后制成散剂。
实施例5
本实施例的目的在于提供一种中药组合物,包括以下原料:白背叶根30g,黄莲6g,鸡骨草15g,田基黄8g,满天星20g,地胆草7g,驳骨草23g,蛇舌草13g以及大黄9g,柴胡10g,甘草20g。
该组合物的制备方法具体如下:
按量称取原料,将330ml水与26ml乙醇混合得到浸泡液,然后将称取好的原料加入浸泡液中,超声浸泡0.5小时,超声的频率为35kHz,加6倍量水煎煮,以武火煎煮至沸腾,再文火煎煮,保持微沸1小时,纱布滤过,药渣继续加6倍量浸泡液煎煮2次,每次各煎0.5小时,合并三次滤液,浓缩,干燥,研磨成粉末。
将中药组合物研磨成粒径为140目的粉末,然后制成颗粒剂。
实施例6
本实施例的目的在于提供一种中药组合物,包括以下原料:白背叶根30g,黄莲6g,鸡骨草15g,田基黄8g,满天星20g,地胆草7g,驳骨草23g,蛇舌草13g以及大黄9g,牛蒡子26g、金银花16g。。
该组合物的制备方法具体如下:
按量称取原料,将340ml水与18ml乙醇混合得到浸泡液,然后将称取好的原料加入浸泡液中,超声浸泡0.5小时,超声的频率为35kHz,加6倍量水煎煮,以武火煎煮至沸腾,再文火煎煮,保持微沸1小时,纱布滤过,药渣继续加6倍量浸泡液煎煮2次,每次各煎0.5小时,合并三次滤液,浓缩,干燥,研磨成粉末。
将中药组合物研磨成粒径为150目的粉末,然后制成口服液。
效果例
黄疸型肝炎临床症状观察的结果如下:
从患者开始有症状到出现黄疸这段时间,约为数日至二周;起病时患者常感畏寒、发热,体温38℃左右,少数患者可持续高热数日;更为突出的症状是全身疲乏无力、食欲减退、恶心、呕叶,尤其厌恶油腻食物,上腹部堵胀满闷,尿黄似浓茶水,大便较稀或便秘;在这阶段因个体差异、患者表现复杂多样易被误诊,应特别注意,如有的患者表现为上呼吸道炎症,类似感冒;有些患者可伴关节酸痛而被误认为风湿病;也有少数人有剧烈腹痛而误认为急腹症;还有少数人可出现等麻疹。查体可发现肝区叩击痛及压痛,半数以上患者肋缘下可触及肝脏,血清丙氨酸氨基转移酶(ALT)明显升高,血清总胆红素(SB)在17.1μmol/L以上,;乙肝表面抗原阳性、乙肝核心抗体免疫球蛋白M(抗-HBcIgM)阳性。
疗效观察:
临床症状:目黄,体黄,小便黄,纳差,乏力;
肝功能:总胆红素(SB)、丙氨酸氨基转移酶(ALT)、谷草转氨酶(AST)、谷氨酰基转肽酶(Y-GT);
疗效标准根据国家中医药管理局发布的中医病诊断疗效标准制定:
治愈:黄疸消退,其它症状消失;
有效:黄疸及其它症状减轻,胆红素正常或降低;
无效:黄疸不退或加深,其它症状无改善。
征集患有黄疸型肝炎的患者180例,年龄6-70岁,平均年龄(32±4.21)岁。病程最短1个月,最长6.5年。具体地,将患者根据症状均分为6组,分别为实施例1-6组,每组30名;其中,多数患者不同程度的出现食欲不振,口苦,舌苔黄,肝区疼痛,小便发黄。
将实施例1-6的组合物分别制成药物,且药剂层中组合物含量相同,含量误差小于0.03%。将实施例1-6制备的贴剂分别贴于患处,使用方法为,每日1剂,每日2次,连续使用一周后,观察治疗效果,具体见表1。
表1治疗结果
由表可见,治疗肝功能变化差异极为显著,本发明的中药组合物在治疗黄疸型肝炎疗效确切,具有廉价、有效的特点,能节约有限的卫生资源,诚轻社会和家庭经济负担,值得在临床上推广使用。
典型病例1:
邓某,女,22岁,患黄疸肝炎,困乏无力,食欲不振,消瘦,肝区疼痛,后经治疗,三天肝区疼痛减轻,十天效果明显,二十天彻底治愈。
典型病例2:
卢某,男,30岁,皮肤、眼球巩膜等部份发黄,尿黄如茶,体温38.2℃,伴有恶心、肝区疼痛、纳差,食欲不振等症状。经检查总胆红素定量63μmo1/L,确诊为黄疸型肝炎。服药3天后病情好转,体温正常,食欲增加,两个疗程后,经医院复查,胆红素定量16.8μmo1/L,各项指标正常,病症治愈。
典型病例3:
张某,男,63岁,发烧38℃,全身乏力,精神欠佳,食欲不振,口苦,舌苔黄,上腹部胀感或不适,小便发黄,体征:巩膜不黄,肝肿大伴隐痛;实验室检查:小三阳伴肝功能异常ALT:668单位,AST:589单位,Y-GT:248单位。服用本发明中药组合物一个疗程后,食欲大增,黄疸减轻,又服用本发明中药组合物1个疗程复查:肝功能各项指标已正常。
典型病例4:
刘某,女,6岁。皮肤、眼球巩膜等部份发黄,尿黄如茶,体温38.2℃,伴有恶心、肝区疼痛、纳差,食欲不振等症状。经检查确诊为黄疸型肝炎。服用本发明中药组合物,剂量为每次2粒,每天3次,三天后病情好转,体温正常,食欲增加,两个疗程后,经市人民医院复查,各项指标正常,病症痊愈。
由上表病例可得,本申请实施例提供的中药组合物,不仅治疗效果好,而且见效较快,具有较高实用价值和使用价值。
综上所述,第一,本申请实施例提供一种中药组合物,包括按重量份数计的以下原料:白背叶根5-50份,黄莲5-10份,鸡骨草5-20份,田基黄5-15份,满天星5-30份,地胆草5-10份,驳骨草5-30份,蛇舌草5-20份以及大黄5-15份。该组合物以白背叶根、鸡骨草和满天星治疗黄疸型肝炎,疏肝止痛,以黄莲、田基黄和驳骨草清热解毒,治疗并发症感冒发烧,以大黄、蛇舌草和地胆草利湿去黄,逐瘀通经。从而使其具有清热解毒、逐瘀通经、利湿退黄、疏肝止痛之功效,从而达到预期的治疗效果。经临床实践证明此九味中药相互作用,相互协同,具有清热解毒、化瘀散结、解毒利胆、抗毒护肝,祛瘀生新之功效。
第二,本申请实施例提供一种中药组合物的制备方法,该制备方法以水-乙醇混合溶液作为溶剂在煎煮的条件下将有效成分提取出来,不仅简单易行,而且可有效提升有效成分的溶出率,制备效果较好,适合批量化工业生产。
第三,本申请实施例提供一种中药组合物在制备治疗黄疸型肝炎的药物中的应用,将上述组合物制成药物,用于治疗黄疸型肝炎不仅治疗效果好,而且见效较快。相比传统需要煎煮的中药,更加方便服用和携带,患者不需要每天煎煮,更加节省时间。另外,原料全部为纯天然药材,且简单易得,无刺激,无毒副作用,制法简单易操作,可见,该组合物的实用价值和使用价值较高。
以上所描述的实施例是本申请一部分实施例,而不是全部的实施例。本申请的实施例的详细描述并非旨在限制要求保护的本申请的范围,而是仅仅表示本申请的选定实施例。基于本申请中的实施例,本领域普通技术人员在没有作出创造性劳动前提下所获得的所有其他实施例,都属于本申请保护的范围。
Claims (10)
1.一种中药组合物,其特征在于,包括按重量份数计的以下原料:
白背叶根5-50份,黄莲5-10份,鸡骨草5-20份,田基黄5-15份,满天星5-30份,地胆草5-10份,驳骨草5-30份,蛇舌草5-20份以及大黄5-15份。
2.根据权利要求1所述的中药组合物,其特征在于,按重量份数计还包括柴胡10-20份和甘草15-20份。
3.根据权利要求1所述的中药组合物,其特征在于,按重量份数计还包括牛蒡子13-26份和金银花8-16份。
4.根据权利要求2或3所述的中药组合物,其特征在于,按重量份数计包括以下原料:白背叶根30份,黄莲6份,鸡骨草15份,田基黄8份,满天星20份,地胆草7份,驳骨草23份,蛇舌草13份以及大黄9份。
5.一种如权利要求4任一项所述的中药组合物的制备方法,其特征在于,包括以下步骤:
按量称取原料,加入浸泡液浸泡0.5~1小时,加6~8倍量水煎煮,以武火煎煮至沸腾,再文火煎煮,保持微沸1~1.5小时,纱布滤过,药渣继续加5~6倍量浸泡液煎煮2次,每次各煎0.5~1小时,合并三次滤液,浓缩,干燥,研磨成粉末。
6.根据权利要求5所述的中药组合物的制备方法,其特征在于,所述浸泡液中水和乙醇的体积比为((300-350):(10-30)。
7.根据权利要求5所述的中药组合物的制备方法,其特征在于,在浸泡过程中,进行超声溶解,且所述超声的频率为35kHz-45kHz。
8.根据权利要求5所述的中药组合物的制备方法,其特征在于,所述粉末的粒径为100-150目。
9.根据权利要求6-8任一项所述的中药组合物的制备方法,其特征在于,还包括将所述粉末制成丸剂、胶囊剂、片剂、散剂、颗粒剂或口服液。
10.一种如权利要求9任一项所述的中药组合物在制备治疗黄疸型肝炎的药物中的应用。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210272152.1A CN114558064A (zh) | 2022-03-18 | 2022-03-18 | 一种中药组合物、制备方法及应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210272152.1A CN114558064A (zh) | 2022-03-18 | 2022-03-18 | 一种中药组合物、制备方法及应用 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN114558064A true CN114558064A (zh) | 2022-05-31 |
Family
ID=81719420
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210272152.1A Pending CN114558064A (zh) | 2022-03-18 | 2022-03-18 | 一种中药组合物、制备方法及应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114558064A (zh) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1911059A (zh) * | 2006-08-19 | 2007-02-14 | 李浪辉 | 田基黄鸡骨草凉茶 |
CN102008645A (zh) * | 2010-12-10 | 2011-04-13 | 冯学安 | 用于治疗黄疸肝炎的中药胶囊 |
CN102824482A (zh) * | 2012-09-25 | 2012-12-19 | 陈兴旺 | 一种治疗黄疸型肝炎的中药组合物 |
CN108310243A (zh) * | 2018-04-18 | 2018-07-24 | 何子均 | 用于专治遗传性黄疸肝炎的中药及其制备方法 |
-
2022
- 2022-03-18 CN CN202210272152.1A patent/CN114558064A/zh active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1911059A (zh) * | 2006-08-19 | 2007-02-14 | 李浪辉 | 田基黄鸡骨草凉茶 |
CN102008645A (zh) * | 2010-12-10 | 2011-04-13 | 冯学安 | 用于治疗黄疸肝炎的中药胶囊 |
CN102824482A (zh) * | 2012-09-25 | 2012-12-19 | 陈兴旺 | 一种治疗黄疸型肝炎的中药组合物 |
CN108310243A (zh) * | 2018-04-18 | 2018-07-24 | 何子均 | 用于专治遗传性黄疸肝炎的中药及其制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103393821A (zh) | 一种治疗慢性盆腔炎的中药组合物及其制备方法 | |
CN104173937A (zh) | 一种疏肝利胆的中药组合物及其应用 | |
CN103417745A (zh) | 一种治疗急性胆囊炎的中药制剂及其制备方法 | |
CN103920034A (zh) | 减轻肿瘤病人化疗副反应的中药组合物及制法 | |
CN100368008C (zh) | 一种治疗妇科疾病的中药及其制备工艺 | |
CN104623376B (zh) | 用于治疗三叉神经痛的药物 | |
CN105560531A (zh) | 治疗小儿湿疹的中药组合物及其制备方法 | |
CN105999058B (zh) | 鬼针草降脂片 | |
CN115282229A (zh) | 一种治疗气虚血淤型冠心病的中药组合物及其制备方法 | |
CN104225490A (zh) | 一种治疗胆囊炎的中药 | |
CN103893611A (zh) | 一种治疗肾结石的药物及制备方法 | |
CN114558064A (zh) | 一种中药组合物、制备方法及应用 | |
CN103638357A (zh) | 一种用于防治流行性脑膜炎的中药组合物及其制备方法 | |
CN1517115A (zh) | 治疗慢性盆腔炎的中成药——妇炎胶囊 | |
CN103520652A (zh) | 一种治疗肝癌的中药组合物 | |
CN104116805A (zh) | 一种治疗盆腔淤血综合征的中药制剂 | |
CN101961481A (zh) | 一种治疗肝胆气郁型胆囊炎的中药及其制备方法 | |
CN105497863A (zh) | 治疗急性乳腺炎的中药组合物 | |
CN105477246A (zh) | 一种治疗痰湿型乳腺增生的中药组合物及其制备方法 | |
CN105497312A (zh) | 一种治疗阑尾炎的中药组合物 | |
CN105106334A (zh) | 一种用于治疗乳腺增生的药物制剂 | |
CN104524460A (zh) | 一种防治急性肾炎的药物组合物及其应用 | |
CN104586998A (zh) | 一种治疗急性胆囊炎的中药制剂及其制备方法 | |
CN104645233A (zh) | 一种治疗乳腺增生的中药制剂 | |
CN104524149A (zh) | 一种防治急性肾炎的药物组合物及其应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20220531 |